Compare SYY & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYY | HLN |
|---|---|---|
| Founded | 1969 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Food Distributors | Package Goods/Cosmetics |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.9B | 42.8B |
| IPO Year | 2004 | 2021 |
| Metric | SYY | HLN |
|---|---|---|
| Price | $79.47 | $9.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 1 |
| Target Price | ★ $87.62 | N/A |
| AVG Volume (30 Days) | 3.1M | ★ 12.5M |
| Earning Date | 04-28-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.97% | 1.94% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.66 | N/A |
| Revenue | ★ $84,553,000,000.00 | N/A |
| Revenue This Year | $4.83 | $6.55 |
| Revenue Next Year | $4.96 | $4.42 |
| P/E Ratio | ★ $21.61 | $49.05 |
| Revenue Growth | ★ 3.91 | N/A |
| 52 Week Low | $68.19 | $8.65 |
| 52 Week High | $91.85 | $11.28 |
| Indicator | SYY | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 40.67 | 37.81 |
| Support Level | $77.94 | $9.08 |
| Resistance Level | $85.27 | $9.29 |
| Average True Range (ATR) | 1.64 | 0.15 |
| MACD | -0.27 | -0.05 |
| Stochastic Oscillator | 17.69 | 13.64 |
Sysco is the largest foodservice distributor in the US, with an 18% share of the $377 billion vertical. The firm sells and distributes over 500,000 food and nonfood products to about 730,000 customer locations, primarily serving restaurants, which represented 60% of fiscal 2025 sales. The balance of sales stems from healthcare facilities (8%), education and government customers (8%), travel and leisure clients (7%), and other smaller end markets (17%), like cafeterias. By segment, Sysco earns the bulk of its revenue from its US foodservice operations (70%), followed by its international footprint (18%), SYGMA, which focuses on quick-service logistics (10%), and other (2%). The pending Jetro Restaurant Depot deal stands to add $16 billion in sales upon close, expected in fiscal 2027.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.